Lazards at first nutty $21 dollar call follows a history with Insmed. Hyping Insmed in 05 and 08,all the while being the short interest bank,Lazard like most brokerages has an agenda.
The analyst for Lazard pumping iplex was none other than Matt Osbourne,who since was IR for Vertex and now is IR for Synageva. Connect the dots.
The last chart catalyst is the 12 dollar mark